drugset / Trial / NCT01048983
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
RandomizedSingle-groupTriple-blindSupportive care
Summary
The goal of this clinical research study is to compare armodafinil, bupropion, curcumin, and minocycline when given alone or in combination to learn which is better for controlling symptoms, such as the side effects of chemoradiation, when given to treat lung cancer.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Armodafinil | Small molecule | 150 mg | Oral |
| Comparator | Bupropion | Small molecule | 100 mg | Oral |
| Comparator | Curcumin | Small molecule | 4 g | Oral |
| Comparator | Minocycline | Small molecule | 100 mg | Oral |